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Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, has a 
prevalence that increases with age.(1) AF is associated with a 4-5 fold increased risk 
of ischaemic stroke(2) and strokes attributable to AF are associated with greater 
morbidity, mortality and healthcare costs.(3) Untreated AF and subsequent stroke 
disease, therefore, pose a significant public health burden.(4)  
Oral anticoagulation reduces the risk of ischaemic stroke by two-thirds in people 
with AF and, if undiagnosed AF can be accurately identified and treated, there is 
great potential for reducing AF thromboembolic complications.(5) Around 12% of 
patients with AF are asymptomatic and it is prevalent in at least 12% of patients at 
first presentation of ischaemic stroke.(6) Optimal identification and treatment of AF 
could prevent substantial numbers of strokes and have a major impact on public 
health. 
Screening for AF, using opportunistic pulse palpation and confirmatory 12-lead 
electrocardiogram (ECG) in those found with an irregular pulse, has been 
recommended in patients aged 65 years and over.(7) A systematic review of 30 AF 
screening studies from nine countries(8) found a pooled AF prevalence (95% 
Confidence Interval (C.I)) of 2.3% (2.2-2.4); the incidence of previously undiagnosed 
AF was 1.0% (0.89-1.04) in screened populations. Both prevalence and incidence of 
new AF was higher in studies conducted within a General Practice (GP) or outpatient 
setting. Sub-group analyses of patients ≥65 years found the prevalence of AF 
significantly increased to 4.4% (4.1-4.6) and the incidence of AF increased to 1.4% 
(1.2-1.6). However, further research is needed that investigates the impact of 
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screening on clinical outcomes, such as stroke prevention, as compared to non-
screened populations.  
 
It is unclear how AF screening is best organized; screening could be opportunistic or 
systematic. The Screening for Atrial Fibrillation in the Elderly study, a cluster-
randomized trial set in 50 English GP practices, was the largest study that compared 
the efficacy of opportunistic screening (pulse palpation followed by 12-lead ECG in 
those with an irregular pulse) and systematic screening (12-lead ECG for all patients) 
with usual care in patients ≥65 years age.(9) Fitzmaurice and colleagues reported a 
greater incidence of new AF from intervention practices (1.63% versus 1.04%; 
absolute difference 0.59%, 95% C.I 0.20-0.98).(9) There was no difference in newly 
detected AF between the two screening approaches (1.64% for opportunistic 
screening and 1.62% for systematic screening) but economic analyses from this 
study suggested opportunistic screening was more cost-effective.(10) 
 
Based on this trial data, current recommendations assume the optimal configuration 
for screening is the two-stage approach of pulse palpation followed by confirmatory 
12-lead. A recent meta-analysis suggested alternative methods to pulse palpation, 
such as blood pressure monitors (BPMs) and non-12-lead ECG (e.g. single-lead ECG), 
may be more accurate at detecting pulse irregularities attributable to AF [Sensitivity 
(95% C.I) and specificity (95% C.I) for BPMs: 0.98 (0.92-1.00), 0.92 (0.88-0.95); non-
12-lead ECG: 0.91 (0.86-0.94), 0.95 (0.92-0.97); pulse palpation: 0.92 (0.85-0.96), 
0.82 (0.76-0.88)].(11) Due to the lower specificity for pulse palpation, this method of 
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detecting pulse irregularities may result in higher false positive cases of suspected AF 
and other methods may provide greater accuracy for this first-step of screening.   
 
The gold standard test for diagnosing AF is 12-lead ECG interpreted by a competent 
professional, the recommended second-step of AF screening. Another meta-analysis 
investigated the accuracy of methods for interpreting 12-lead ECGs for diagnosing 
AF.(12) Taggar and colleagues reported automated software analysis had the greatest 
specificity for AF diagnosis, although the sensitivities were similar for software and 
any healthcare professional (HCP) diagnosed AF. [Sensitivity (95% C.I) and specificity 
(95% C.I) for automated software: 0.89 (0.82-0.93), 0.99 (0.99-0.99), any HCP: 0.92 
(0.81-0.97), 0.93 (0.76-0.98)]. Sub-group analyses of primary care professionals 
found a greater accuracy for General Practitioner (GP) than nurse diagnosed AF, 
which was due to the lower specificity of nurse ECG interpretation for diagnosing AF 
[Sensitivity (95% C.I) and specificity (95% C.I) for GP: 0.91 (0.68-1.00), 0.96 (0.89-
1.00); nurses: 0.88 (0.63-1.00), 0.85 (0.83-0.87)]. However, these findings also 
suggest the ability of primary HCPs to accurately diagnose AF should be improved to 
ensure maximal effectiveness of screening. 
 
Despite optimizing the configuration of AF screening, for this to be successfully and 
consistently introduced within primary care, it would be important to ensure that 
primary care infrastructure, such as access to ECG equipment and staffing, can 
support screening activities. AF screening would result in a greater number of 
patient contacts, ECGs performed and interpreted, and consequent prescribing and 
monitoring of anti-thrombotic medication. To date, there have been no studies that 
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have investigated the feasibility of introducing screening within a primary care 
setting or the opinions of primary care professionals about screening activities. For 
maximal success, the professionals chosen to deliver screening, whether GPs or 
nurses, would require enthusiasm for this new responsibility. Research that 
investigates current practice, knowledge, skills and attitudes to AF screening by 
professionals working in primary care is important as understanding the facilitators 
and barriers to delivering AF screening are imperative to its successful 
implementation.  
 
In conclusion, screening has been shown to be efficacious in detecting asymptomatic 
incident cases of AF. However, research suggests other technologies, such as 
modified BPMs and non-12-lead ECGs may have an important role for the initial 
identification of suspected AF. Moreover, if screening were implemented within a 
primary care setting, it is likely that training to improve the skills of HCPs to 
accurately diagnose this arrhythmia would be required to ensure maximal 
effectiveness of screening. This would be particularly important in regions where 
ECG interpretation is not part of routine practice.   
 
Competing interests: None 
Funding: JT is funded by Nottingham City CCG 
Author contributions: JT conceived and drafted the manuscript; TC critically 
reviewed and amended the manuscript. All gave final approval and agree to be 
accountable for all aspects of work ensuring integrity and accuracy 
  
 5 
REFERENCES  
 
1. Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY, et al. Prevalence of 
atrial fibrillation in the general population and in high-risk groups: the ECHOES study. 
Europace. 2012;14:1553-9. doi: 10.093/europace/eus087. Epub 2012 Apr 5. 
2. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of 
stroke in patients with atrial fibrillation: a systematic review. Neurology. 
2007;69:546-54. 
3. Bruggenjurgen B, Rossnagel K, Roll S, Andersson FL, Selim D, Muller-
Nordhorn J, et al. The impact of atrial fibrillation on the cost of stroke: the berlin 
acute stroke study. Value in health : the journal of the International Society for 
Pharmacoeconomics and Outcomes Research. 2007;10:137-43. 
4. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an 
emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 
2004;90:286-92. 
5. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to 
prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 
2007;146:857-67. 
6. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial 
fibrillation in patients with cryptogenic stroke. The New England journal of medicine. 
2014;370:2467-77. 
7. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 
focused update of the ESC Guidelines for the management of atrial fibrillation: an 
update of the 2010 ESC Guidelines for the management of atrial fibrillation--
developed with the special contribution of the European Heart Rhythm Association. 
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of 
the working groups on cardiac pacing, arrhythmias, and cardiac cellular 
electrophysiology of the European Society of Cardiology. 2012;14:1385-413. 
8. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown 
atrial fibrillation. A systematic review. Thrombosis and haemostasis. 2013;110:213-
22. 
9. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. 
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 
or over: cluster randomised controlled trial. BMJ. 2007;335:383. Epub 2007 Aug 2. 
10. Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A 
randomised controlled trial and cost-effectiveness study of systematic screening 
(targeted and total population screening) versus routine practice for the detection of 
atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 
2005;9:iii-iv, ix-x, 1-74. 
11. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for 
detecting an irregular pulse and suspected atrial fibrillation: A systematic review and 
meta-analysis. European journal of preventive cardiology. 2015:pii: 
2047487315611347. [Epub ahead of print]. 
12. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for 
diagnosing atrial fibrillation using 12-lead ECG: A systematic review and meta-
analysis. International journal of cardiology. 2015;184:175-83. 
 
